Confounding influence of tamoxifen in mouse models of Cre recombinase-induced gene activity or modulation

Area of Science:

• Toxicology
• Pharmacology
• Molecular Biology

Background:

• Tamoxifen (TAM) is widely used for inducible gene manipulation in research.
• Potential confounding effects of TAM on experimental outcomes, especially in liver studies, require investigation.
• The impact of TAM on chemically induced liver injury is not fully understood.

Purpose of the Study:

• To investigate the effect of TAM on carbon tetrachloride (CCl4)-induced hepatotoxicity in mice.
• To elucidate the underlying mechanisms of TAM's protective effects against liver injury.
• To assess the implications of TAM's metabolic effects for inducible gene expression studies.

Main Methods:

• Male C57Bl/6N mice were pretreated with TAM before CCl4 administration.
• Liver injury was assessed by measuring necrosis index and transaminase levels.
• Hepatic CYP2E1 expression and activity were analyzed.
• Levels of antioxidants and phase II metabolizing enzymes were quantified.
• Immunohistochemical staining (F4/80, CD45) was used to evaluate immune cell infiltration.

Main Results:

• TAM significantly reduced CCl4-induced liver necrosis and transaminase levels.
• TAM pretreatment downregulated hepatic CYP2E1 expression and activity.
• TAM increased levels of antioxidants (ascorbate, catalase, SOD2, methionine) and phase II enzymes (GSTM1, UGT1A1).
• TAM enhanced macrophage presence and immune cell recruitment in injured liver areas.

Conclusions:

• Tamoxifen confers significant protection against CCl4-induced hepatotoxicity in mice.
• TAM's protective effects are mediated by modulating metabolic enzymes, boosting antioxidant defenses, and influencing immune responses.
• Researchers using TAM-inducible systems, especially with hepatotoxic compounds, must consider TAM's inherent biological effects.